HSBC has raised its price target on Glenmark Pharma by over 32% to 2,275 per share from 1,720 apiece. Previous Post Analysts suggest buying RBL Bank, Paytm, CONCOR & selling HAL, BDL, Siemens Next Post Motilal Oswal gives Suzlon Energy its highest share price target based on these key triggers Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
